CYP2A6 and lung cancer: The mixed-smoker status studies yielded non-significant findings or smaller risk estimates, which may be explained by the fact that the probability of lung cancer occurrence may be similar among never-smokers with different CYP2A6 genotypes, where the resulting phenotype is not expressed in people who do not smoke.